PDCD1 and neoplasm: The interaction of the programmed cell death protein 1 (PD-1) and its ligand (PD-L1 or PD-L2) may increase aerobic glycolysis in tumor cells by suppressing the PI3K-AKT-mTOR signal transduction pathway, thereby inhibiting T-cell activation while promoting immune escape [97, 98].